Attach to Form 990 or Form 990-EZ.
Go to
www.irs.gov/Form990 for the latest information.
| (i) Name of supported organization | (ii) EIN | (iii) Type of organization (described on lines 1- 10 above (see instructions)) | (iv) Is the organization listed in your governing document? | (v) Amount of monetary support (see instructions) | (vi) Amount of other support (see instructions) | |
|---|---|---|---|---|---|---|
| Yes | No | |||||
|
Total |
||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2014 | (b) 2015 | (c) 2016 | (d) 2017 | (e) 2018 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grant.") .. | ||||||
| 2 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf.... | ||||||
| 3 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | ||||||
| 4 | Total. Add lines 1 through 3 | ||||||
| 5 | The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f).. | ||||||
| 6 | Public support. Subtract line 5 from line 4. | ||||||
Calendar year
(or fiscal year beginning in) ![]() |
(a) 2014 | (b) 2015 | (c) 2016 | (d) 2017 | (e) 2018 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 7 | Amounts from line 4.. | ||||||
| 8 | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... | ||||||
| 9 | Net income from unrelated business activities, whether or not the business is regularly carried on.. | ||||||
| 10 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.).. | ||||||
| 11 | Total support. Add lines 7 through 10 | ||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2014 | (b) 2015 | (c) 2016 | (d) 2017 | (e) 2018 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") . | ||||||
| 2 | Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose | ||||||
| 3 | Gross receipts from activities that are not an unrelated trade or business under section 513 ..... | ||||||
| 4 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf... | ||||||
| 5 | The value of services or facilities furnished by a governmental unit to the organization without charge | ||||||
| 6 | Total. Add lines 1 through 5 | ||||||
| 7a | Amounts included on lines 1, 2, and 3 received from disqualified persons | ||||||
| b | Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year. | ||||||
| c | Add lines 7a and 7b.. | ||||||
| 8 | Public support. (Subtract line 7c from line 6.) | ||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2014 | (b) 2015 | (c) 2016 | (d) 2017 | (e) 2018 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 9 | Amounts from line 6... | ||||||
| 10a | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. | ||||||
| b | Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975. | ||||||
| c | Add lines 10a and 10b. | ||||||
| 11 | Net income from unrelated business activities not included in line 10b, whether or not the business is regularly carried on. | ||||||
| 12 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) .. | ||||||
| 13 | Total support. (Add lines 9, 10c, 11, and 12.).. | ||||||
| Section A - Adjusted Net Income | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Net short-term capital gain | 1 | ||||
| 2 | Recoveries of prior-year distributions | 2 | ||||
| 3 | Other gross income (see instructions) | 3 | ||||
| 4 | Add lines 1 through 3 | 4 | ||||
| 5 | Depreciation and depletion | 5 | ||||
| 6 | Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) | 6 | ||||
| 7 | Other expenses (see instructions) | 7 | ||||
| 8 | Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) | 8 | ||||
| Section B - Minimum Asset Amount | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): | 1 | ||||
| a | Average monthly value of securities | 1a | ||||
| b | Average monthly cash balances | 1b | ||||
| c | Fair market value of other non-exempt-use assets | 1c | ||||
| d | Total (add lines 1a, 1b, and 1c) | 1d | ||||
| e |
Discount claimed for blockage or other factors (explain in detail in Part VI): |
|||||
| 2 | Acquisition indebtedness applicable to non-exempt use assets | 2 | ||||
| 3 | Subtract line 2 from line 1d | 3 | ||||
| 4 | Cash deemed held for exempt use. Enter 1-1/2% of line 3 (for greater amount, see instructions). | 4 | ||||
| 5 | Net value of non-exempt-use assets (subtract line 4 from line 3) | 5 | ||||
| 6 | Multiply line 5 by .035 | 6 | ||||
| 7 | Recoveries of prior-year distributions | 7 | ||||
| 8 | Minimum Asset Amount (add line 7 to line 6) | 8 | ||||
| Section C - Distributable Amount | Current Year | |||||
| 1 | Adjusted net income for prior year (from Section A, line 8, Column A) | 1 | ||||
| 2 | Enter 85% of line 1 | 2 | ||||
| 3 | Minimum asset amount for prior year (from Section B, line 8, Column A) | 3 | ||||
| 4 | Enter greater of line 2 or line 3 | 4 | ||||
| 5 | Income tax imposed in prior year | 5 | ||||
| 6 | Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) | 6 | ||||
| Section D - Distributions | Current Year | |
|---|---|---|
| 1 Amounts paid to supported organizations to accomplish exempt purposes | ||
|
2
Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in excess of income from activity |
||
| 3 Administrative expenses paid to accomplish exempt purposes of supported organizations | ||
| 4 Amounts paid to acquire exempt-use assets | ||
| 5 Qualified set-aside amounts (prior IRS approval required) | ||
| 6 Other distributions (describe in Part VI). See instructions | ||
| 7Total annual distributions. Add lines 1 through 6. | ||
|
8
Distributions to attentive supported organizations to which the organization is responsive (provide details in Part VI). See instructions |
||
| 9 Distributable amount for 2018 from Section C, line 6 | ||
| 10 Line 8 amount divided by Line 9 amount | ||
| Section E - Distribution Allocations (see instructions) |
(i) Excess Distributions |
(ii) Underdistributions Pre-2018 |
(iii) Distributable Amount for 2018 |
|
|---|---|---|---|---|
|
1
Distributable amount for 2018 from Section C, line 6 |
||||
|
2
Underdistributions, if any, for years prior to 2018 (reasonable cause required-- explain in Part VI). See instructions. |
||||
| 3 Excess distributions carryover, if any, to 2018: | ||||
| a From 2013....... | ||||
| b From 2014....... | ||||
| c From 2015....... | ||||
| d From 2016....... | ||||
| e From 2017....... | ||||
| fTotal of lines 3a through e | ||||
| g Applied to underdistributions of prior years | ||||
| h Applied to 2018 distributable amount | ||||
|
i
Carryover from 2013 not applied (see instructions) |
||||
| j Remainder. Subtract lines 3g, 3h, and 3i from 3f. | ||||
| 4Distributions for 2018 from Section D, line 7: | ||||
| $ | ||||
| a Applied to underdistributions of prior years | ||||
| b Applied to 2018 distributable amount | ||||
| c Remainder. Subtract lines 4a and 4b from 4. | ||||
|
5
Remaining underdistributions for years prior to 2018, if any. Subtract lines 3g and 4a from line 2. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
6
Remaining underdistributions for 2018. Subtract lines 3h and 4b from line 1. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
7 Excess distributions carryover to 2019. Add lines 3j and 4c. |
||||
| 8 Breakdown of line 7: | ||||
| a Excess from 2014...... | ||||
| b Excess from 2015..... | ||||
| c Excess from 2016..... | ||||
| d Excess from 2017..... | ||||
| e Excess from 2018..... | ||||
| Facts And Circumstances Test |
|---|
| Return Reference | Explanation |
|---|
| Software ID: | |
| Software Version: |
Attach to Form 990 or 990-EZ.
Go to www.irs.gov/Form990 for the latest information.
| Return Reference | Explanation |
|---|---|
| FORM 990, PART I, LINE 6 | FROM TEENAGERS TO GREAT GRANDPARENTS, FROM HOMEMAKERS TO PROFESSIONAL ATHLETES, CHILDREN'S HOSPITAL COLORADO VOLUNTEERS ENCOMPASS ALL WALKS OF LIFE AND ALL INCOME LEVELS, EACH VOLUNTEER WITH SOMETHING UNIQUE TO OFFER. OUR DIVERSE GROUP OF VOLUNTEERS HAS ONE THING IN COMMON, HOWEVER, THE DESIRE TO HELP SICK CHILDREN AND THEIR FAMILIES. CHILDREN'S HOSPITAL COLORADO IS FORTUNATE TO HAVE HUNDREDS OF DEDICATED VOLUNTEERS WHO WORK REGULARLY, FROM SEVERAL HOURS A YEAR TO SEVERAL HOURS A WEEK, TO PROVIDE BETTER CARE FOR THE CHILDREN OF CHILDREN'S HOSPITAL COLORADO. THE ASSOCIATION OF VOLUNTEERS THE VOLUNTEERS AT CHILDREN'S HOSPITAL COLORADO ARE ALL PART OF A GROUP CALLED CHILDREN'S HOSPITAL COLORADO ASSOCIATION OF VOLUNTEERS (AOV). THE AOV COORDINATES PLACEMENTS FOR VOLUNTEERS AND ENSURES THAT COMPLETE ORIENTATION AND TRAINING IS PROVIDED TO ALL VOLUNTEERS. OUR VOLUNTEER'S SKILLS AND INTERESTS ARE ALL SO APPRECIATED AND WE TRY TO PLACE EVERYONE IN A ROLE THAT SUITS THEM AND OUR NEEDS. THE EXAMPLES BELOW ARE JUST SOME OF THE WAYS THAT OUR VOLUNTEERS CONTRIBUTE: - VOLUNTEERS ARE ACTIVE AT THE HOSPITAL ON THE ANSCHUTZ MEDICAL CAMPUS, THE SOUTH CAMPUS, HIGHLANDS RANCH THERAPY CARE CENTER, BRIARGATE, AND THE NORTH CAMPUS. - VOLUNTEERS SPEND TIME WITH OUR PATIENTS BY HOLDING, COMFORTING, PLAYING WITH THEM AND MAKING THEM LAUGH. - VOLUNTEERS BRING SPECIALLY-SCREENED DOGS TO PROVIDE ANIMAL-ASSISTED THERAPY FOR THE PRESCRIPTION PET PROGRAM. - SPECIALLY TRAINED VOLUNTEERS SERVE AS AMBASSADORS WITH THE WELCOME PROGRAM. VOLUNTEERS GREET NEWLY ADMITTED PATIENT FAMILIES UPON THEIR ARRIVAL AND INTRODUCE THEM TO THE HOSPITAL'S MANY AMENITIES. THE GOAL IS TO PROVIDE A WARM AND WELCOMING ENVIRONMENT AND TO ANSWER ANY NON-MEDICAL QUESTIONS. - THE WINE EVENT IS THE ASSOCIATION OF VOLUNTEERS' SIGNATURE EVENT. THE SPECIAL EVENING FEATURES A SILENT AND LIVE AUCTION OF FINE WINES AND EXPERIENCES WITH ALL PROCEEDS BENEFITING THE MATERNAL FETAL MEDICINE PROGRAM. - MANY GROUPS OF VOLUNTEERS DO NOT SPEND TIME DIRECTLY WITH OUR PATIENTS, BUT PERFORM MORE ADMINISTRATIVE DUTIES, WHICH CAN BE JUST AS IMPORTANT TO THE DAY-TO-DAY OPERATIONS OF CHILDREN'S HOSPITAL COLORADO. - TEENAGERS BETWEEN 13 AND 18 YEARS OF AGE PARTICIPATE IN THE JUNIOR VOLUNTEER PROGRAM. THEY SUPPORT THE HOSPITAL BY WORKING IN SEVERAL DEPARTMENTS AS WELL AS SUPPORTING FUNDRAISING ACTIVITIES. - VOLUNTEERS ALSO ASSIST IN FUNDRAISING BY STAFFING CHILDREN'S HOSPITAL COLORADO GIFT SHOP AND LA CACHE. - CHAPTER VOLUNTEERS IN THE COMMUNITY ARE VERY ACTIVE IN FUNDRAISING EVENTS THROUGHOUT THE YEAR THAT HELP TO FUND SPECIAL EQUIPMENT, FACILITIES AND PROGRAMS FOR THE PATIENTS OF CHILDREN'S HOSPITAL COLORADO. |
| FORM 990, PART III, LINE 4A | RESPIRATORY CARE At Childrens Hospital Colorado, Respiratory Care is part of the Breathing Institute service line. This department cares for a diverse patient population from around the United States, ranging in age from birth to early adulthood. We provide care at three inpatient facilities, four emergency departments, seven outpatient clinic locations, and three outreach clinics in addition to our growing telemedicine outreach. In 2018, we cared for 48% of patients from birth to age 18 hospitalized for respiratory disease in Colorado and 79% of those hospitalized with the most severe respiratory disease. The Respiratory Care team includes 27 Pediatric Pulmonologists (9.23 clinical FTEs), 7 Pediatric Sleep Medicine Physicians (3.45 clinical FTEs), 2 Allergists (0.19 clinical FTEs), 16 Advanced Practice Providers (12.5 clinical FTEs), and 21.73 outpatient RN FTEs. The multidisciplinary care team also includes respiratory therapists, social workers, registered dieticians, physical and speech therapists, psychologists, and health navigators. In 2018, the Breathing Institute had 18,658 outpatient visits (9% increase from 2017), 3,621 inpatient discharges (2% increase from 2017) performed 357 bronchoscopies (19% increase from 2017), 22 laryngoscopies (8% decrease from 2017), and 4,131 sleep studies (2.8% increase from 2017). In 2018, the Respiratory Care team dedicated focused resources to quality improvement, advocacy, and healthcare provider education. Four of those projects have yielded strong results and are described below as our 2018 accomplishments. Quality Initiative: Home Visits for Pediatric Asthma Patients As a result of a previously conducted needs assessment focused on high risk asthma patients seen at Childrens Hospital Colorado, the Breathing Institute created a home visit program for patients with difficult-to-control asthma in 2016. The first two years were focused on program development, hiring and training staff, and conducting quarterly PDSA quality improvement cycles. In 2018, we concluded our pilot phase and incorporated home visits into our clinical operations as standard of care for high risk asthma patients. We conducted 116 home visits with 44 patients. These visits were conducted by a nurse and community health navigators and focused on asthma education, barrier identification and patient navigation, home environmental assessment and trigger remediation. Support provided to each family varies based on barriers identified but commonly includes medication device technique teaching, help with applications for benefits (e.g., Medicaid and WIC paperwork), and remediation supplies such as HEPA-filter vacuums, safe cleaning supplies, and pest extermination services. During the pilot phase that ended in 2018, we saw a 41% reduction in readmissions/emergency department revisits for asthma in the six months following participation in the home visit program. Healthcare Advocacy: Updating Colorados Newborn Screening Law Colorados newborn screening program aims to ensure every Colorado baby receives a genetic, metabolic and hearing screening upon birth. These screenings help identify potentially life-threatening conditions, as well as hearing loss. If these conditions arent identified very early in life, they can lead to severe health consequences and developmental delays or even death. However, that law dates back to the 1990s and did not include screening for many conditions that are standard in other states. Clinicians at Childrens Hospital Colorado, including pulmonologists, approached our Government Affairs team with concerns about these gaps. With help from community partners, we advocated to modernize Colorados newborn screening program by expanding testing to cover new diseases, improving the follow-up process for babies needing additional testing, and ensuring adequate program resources. Pulmonary faculty members provided guidance on bill development and testimony at the Colorado legislature. This bill was signed into law on June 8, 2018. Quality Initiative: Improving Care for Patients with Obstructive Sleep Apnea by Leveraging Electronic Medical Records Since the original description of positive airway pressure (PAP) therapy for treatment of Obstructive Sleep Apnea (OSA) in 1980, the science and evidence of its effectiveness has expanded. Clinical applications of PAP therapy, along with the evolution of improved medical devices using this technology, has outpaced the medical communitys ability to supply and monitor patients who would benefit from PAP therapy. In 2015, the American Academy of Sleep Medicine (AASM) published "Quality Measures for the Care of Pediatric Patients with Obstructive Sleep Apnea" but did not provide specific means to accomplish the outcomes and processes. Improving access to PAP therapy became a quality care, high priority issue at our institution. The increased numbers of patients needing to be assessed and treated overwhelmed our work flow. To effectively capture the ever-growing PAP patient population, a customized report was created to extract data within EMR system to track all new PAP patients from completion of their PAP titration sleep study to subsequent clinic visit. A process map was created to identify communication gaps and 100% of new PAP patients received a call to schedule a follow up visit. Through three quality improvement cycles, the team increased sleep study follow-up clinic visits from 61% at baseline to 88%. Quality Initiative: Simulation Training for Families of Children with Long-term Mechanical Ventilation Preparing families of children requiring long-term mechanical ventilation (LTMV) to manage medical emergencies at home is challenging. Opportunities for family caregivers to rehearse crisis management in a controlled setting before discharge are limited. We created a multimodal discharge preparedness curriculum, incorporating high-fidelity simulation training, to prepare family caregivers of children with complex medical conditions requiring LTMV. We also sought to determine which curricular elements were most helpful and whether this curriculum impacted the rate of readmissions within 7 days of hospital discharge. The curriculum included instructional videos, printed handouts, cardiopulmonary resuscitation training, and two mandatory high fidelity simulation scenarios depicting tracheostomy- and ventilator-related emergencies. Teams of one to three family caregivers per patient managed each scenario. A video-based debriefing focused on identifying and closing performance gaps. Participants rated their perceptions regarding each curricular element and its relative impact on their preparedness for discharge. Eighty-seven family caregivers completed the curriculum. Simulation-enhanced curriculum was well-received by participants. Participants reported that post-simulation debriefing was the most beneficial component. We observed a trend toward reduced readmissions within 7 days of discharge since implementation of our revised curriculum: from 15% 7-day readmission rate (n=20) to 7.9% 7-day readmission rate (n=38). Simulation training can be incorporated into discharge training for families of children requiring LTMV. Rehearsal of emergency management in a simulated clinical setting increases caregiver confidence and preparation to assume care for their ventilator-dependent child at home. Neuroscience Institute Childrens Hospital Colorados (CHCO) Neuroscience Institute (NSI) has one of the best pediatric developmental pediatrics, neurology, and neurosurgery programs in the country. We have consistently ranked among the Top 15 programs by US News & World Report. The NSI provides evaluation and treatment of neurological disorders, parent and patient education, and inpatient and outpatient treatments, therapies and procedures. Our neurology team is specially trained to diagnose and treat disorders of the brain and nervous system, caring for kids with conditions like stroke, neuromuscular disorders, movement disorders, neurometabolic disorders, epilepsy, and migraines. Our neurosurgery team provides surgical treatment for all types of disorders affecting the brain, spinal cord and skull including epilepsy, hydrocephalus, traumatic injury, brain tumors, spina bifida, and facial and skull deformities. Our Developmental Pediatrics team sees children with a variety of developmental and neurobehavioral differences such as autism spectrum disorders, X&Y chromosome variations, fragile X and developmental delays. |
| FORM 990, PART III, LINE 4A CONTINUED | The NSI clinical care team is comprised of Neonatologists, Neonatal Nurse Practitioners, specially trained nurses, respiratory therapists, pharmacists, physical, speech and occupational therapists, lactation specialists, neonatal nutrition, social work, chaplains and case managers. Specialty consultants include neurology, pulmonology, genetics, gastroenterology, nutrition, metabolic, endocrinology, hematology, cardiology and cardiovascular surgery, general pediatric surgery, renal, ophthalmology, orthopedics and ear, nose and throat specialists. NSI includes 50 physicians, 24 advanced practice providers, 27 psychologists across 8 Childrens sites as well as 7 outreach sites across Colorado and a growing telemedicine practice. Our Childrens sites include Anschutz, COS/Briargate, North/Broomfield, Parker, Uptown, Wheatridge, South, Highlands Ranch Therapy. The NSI treated 37,622 patient visits in 2018, serving the Colorado community and our 7-state region. Our Anschutz facility location alone saw 22,260 visits, and we see patients at eight of CHCOs network sites. NSI tripled the number of telemedicine visits in 2018, to 182, and saw almost 500 patient visits in eight outreach clinics across Colorado. Due to the high demand for NSIs services, we have focused on expanding our outreach and telemedicine efforts to better serve patients across Colorado and the 7-state region. Increasing access to care for NSIs specialized services is our high priority to enable our families live healthier lives. NSI Inpatient had 6,822 patient days recorded in 2018. There was a total of 1,236 inpatient discharges in 2018. National/Regional Presence: NSI has an outreach program reaching from Montana to New Mexico with extensive presence in Colorado. We host over 100 Neurology outreach clinics annually across Colorado, in Alamosa, Durango, Ft. Morgan, Grand Junction, Montrose, Pueblo and Sterling. Our Neurologists provide EEG reading services for 8 hospitals/medical centers in Colorado, Nebraska and Montana. Our Developmental Pediatrics team travels throughout the state to train PCPs on best practices in diagnosing and managing patients with autism. In 2018 we expanded our telemedicine efforts significantly, seeing an increase of over 200% in the number of visits. We were successful in arranging physician licensing, credentialing, and contracts in Montana. We are also working to expand our regional partnerships in 2019 we expect to host an outreach and telemedicine clinics in Casper, WY. NSI is acknowledged by the National Association of Epilepsy Centers as a Level 4 Epilepsy Center. We are recognized by the International Foundation for CDKL5 Research as Center of Excellence for Rett patients, drawing patients nationally to be treated by Dr. Tim Benke, an international expert in this area. Our Neurology Complex Drugs Program draw patients from around the region to be treated for complex neurodegenerative diseases, and the program has been recognized as model for care for these treatments. Our faculty offer local and regional CMEs and organize an annual Rett Symposium and regular Seizure Safety Schools for parents and families. Quality Improvement: The NSI is committed to developing quality improvement as a core clinical strategy by continually advancing the effectiveness, efficiency, safety, experience and coordination of the care it provides to its patients. Our Quality Improvement committee meets monthly to review quality and safety metrics and initiatives and has representatives from all three sections. NSI has numerous active Quality & Process Improvement initiatives underway in 2018 (and continuing into 2019), including the following: - A QSRS review that resulted in establishment of medication safety task force impacting prescription practices and improving parental compliance with Rx orders. - Restructured monthly M&M conferences for faculty and trainees to make them more outcome oriented and to facilitate follow-up on progress toward agreed upon goals. - Established clinical pathways for headache, pediatric arterial ischemic stroke, infantile spasms, neonatal seizures after acquired brain injury, traumatic brain injury, neuromuscular disorders, and status epilepticus. - Established dedicated appointments within the infusion center for status migrainosis patients. - Implemented and trained inpatient nurses specifically to neuroscience patient care improving patient outcomes such as unplanned RRT/Codes related to seizures. - Established dedicated inpatient Neurology service and separate Neurocritical Care (for PICU, CICU, NICU) and Neurohospitalist (ED and regular inpatient units) consultative services. - Care team optimization completed to fully integrate medical assistants into clinic practice. - Piloted RN bookend model in our Developmental Pediatrics clinic to increase access - Redesigned our autism intake model to better serve patients As a result of ongoing Quality & Process Improvement initiatives, NSI has seen the following outcomes: - Decreased utilization of free text only sigs used when writing prescriptions by 25% - 50% decrease in EEG lead pressure injuries - 30% improvement in rate of medication reconciliation during telephone encounters - Greater than 90% rate of responding to over 54K annual patient telephone and MyChart encounters within 2 days. - Decreased headache patient visits through the ED, decreased cost to hospital and increased patient access and satisfaction. - Improved referring physician satisfaction with timeliness and quality of input from inpatient Neurology consultations CENTER FOR CANCER AND BLOOD DISORDERS Childrens Hospital Colorados (CHCO) Center for Cancer and Blood Disorders (CCBD) has one of the best pediatric hematology, oncology and bone marrow transplant programs in the country. The CHC CCBD has been ranked in the Top 10 programs by US News & World Report each year. The CCBD treated 34,848 patient visits in 2018, in an effort to serve the Colorado community, as well as our 7-state region. Our Anschutz facility location alone saw 22,914 visits, with our infusion center volume making up 8,632 (38%) of those visits. Our Network of Care sites in Highlands Ranch, Colorado Springs, and our Hemophilia Thrombosis Center on the Anschutz campus serviced 11,934 patient visits in 2018, 3,507 of which were infusions (29%). Because of the depth and breadth of CCBD outpatient services, a large number of our clinic and infusion visits mean that many children can be cared for on an outpatient basis instead of being admitted to the hospital. Limiting hospitalization when possible is our high priority to enable our families live healthier lives. CCBD Inpatient had 11,592 patient days recorded in 2018. The inpatient unit had a total of 8,228 inpatient Hematology and Oncology patient days and 3,158 BMT patient days recorded. There was a total of 1,722 admissions to the inpatient unit in 2016. National/Regional Presence: CCBD has an outreach program reaching from Montana to New Mexico with extensive presence in Colorado. Our outreach clinics in Grand Junction bring Hematology sub-specialty expertise to the Western slope. Our Hemophilia & Thrombosis Center (HTC) provides comprehensive care clinics throughout the region. We host bi-weekly Bone Marrow Transplant teleconferences with cancer programs in New Mexico. Our CCBD nursing program travels throughout the region to train other hospital nurse staff on best practices in chemotherapy administration. CCBD also hosts regional private practice physicians through our Visiting Provider program, inviting them to our Anschutz location to share best care practices with our community partners first hand, and giving them educational materials and strategies to bring home. In 2018 we expanded our telemedicine efforts. We were successful in arranging physician licensing, credentialing, and contracts in Montana and New Mexico. Our HTC faculty successfully treated rural out of state patients via telemedicine in 2018, and they have set the stage for expanding this platform for 2019 and beyond. We are also working to expand our regional partnerships in 2019 we fully expect to host an outreach clinic in Cheyenne, WY. CCBD is acknowledged by Optum as a Center of Excellence for both our Cancer Care as well as our Bone Marrow Transplant program. We are the only pediatric Foundation for the Accreditation of Cellular Therapy (FACT) program in a 16-state region, which brings us the capacity to deliver the most sophisticated stem cell transplant and chimeric antigen receptor T (CAR-T) cell immunotherapy. Our Neuro-Oncology and Experimental Therapeutics programs draw patients nationally and internationally for treatment and clinical trials available in only a few centers in the world. |
| FORM 990, PART III, LINE 4A CONTINUED | CCBD Fellowship Program: Each year we select 4 new fellows to join our highly selective 3-year Accreditation Council of Graduate Medical Education-sanctioned Fellowship Program. Our fellows train in all aspects of sub-specialty care of children, adolescents and young adults with blood and cancer disorders in preparation for a career in academic medicine. We emphasize excellence in clinical care and research, developing fellows in the physician-scientist model with numerous mentors among the faculty such that our graduates acquire the skills and strategies needed for a career as life-long learners, educators, and influential leaders. We have successfully prepared subspecialty pediatricians that provide comprehensive, patient- and family-centered care with particular focus on excellent communication skills, as well as safety and quality improvement. Almost 90% of our graduates go on to prestigious academic positions with leadership positions across the country. Access: CCBD is privileged to have a dedicated Wellness program. This interdisciplinary team is comprised of specialists in Social Work, Psychology, Child Life, Family Navigation, Creative Arts Therapy, Chaplaincy, and Learning Specialists. The Wellness program benefits families and patients by integrating and coordinating clinical services to meet every familys needs at the individual level and increases possibilities for prevention/intervention and on-going care and connection. The CCBD is a home for multiple sub-programs within Oncology, Hematology and BMT. Our Vascular Anomalies Center is a less commonly known program that is a national and regional leader. This interdisciplinary team evaluates and treats vascular anomalies in children. The team includes specialists from Otolaryngology (ear, nose and throat), Plastic Surgery, Dermatology, Hematology, Pediatric General Surgery and Interventional Radiology. This program exemplifies our priority to put the patient first. Our specialists coordinate their care in one patient appointment to minimize the number of visits needed to evaluate and treat the patients condition. Quality Improvement: The CCBD is committed to developing quality improvement as a core clinical strategy by continually advancing the effectiveness, efficiency, safety, experience and coordination of the care it provides to its patients. The Clinical Effectiveness Collaborative (CEC) supports data driven improvement work on clinical effectiveness, operational excellence and value throughout the CCBD, CHC, and the University of Colorado Anschutz Medical Campus with multidisciplinary standing membership drawn from individuals within the CCBD who can provide meaningful review and guidance to projects shared and supported by the CEC. The CEC is broadly representative, multidisciplinary and guides the range of activities and initiatives through which the CCBD is pursuing its clinical, operational, value-driven, and financial improvement goals. One primary function of the CEC is to review and provide feedback related to clinical and operational improvement projects, including measures, PI methods, and project alignment across the CCBD and CHC. The Collaboratives members help guide clinical and operational improvement initiatives, spread successful interventions, identify and recommend strategies to overcome barriers/challenges, and serve as enthusiastic advocates for, participants and leaders of continuous learning and improvement in their respective areas and across the CCBD. The CCBD has several active Quality & Process Improvement initiatives underway in 2018 (and continuing into 2019) to include: - The CCBD outpatient infusion center on the Anschutz Medical Campus significantly surpassed the Childrens Hospital Colorado patient satisfaction goal for 2018. - Standardizing an approach to screening for transfusion-associated iron overload increasing the number of patients identified and treated for this complication and preventing long-term toxicities. - Decreasing length of stay of high-dose methotrexate admissions resulting in more time outside the hospital for children with leukemia and osteosarcoma. - Preventing blood stream infections in patients with a central line/catheter (tube). - Improving time to administration of pain medications with Sickle Cell patients in acute pain. - Decreasing the rate of clostridium difficile infections resulting in decreased mortality, decreased length of inpatient hospital stay and decreased cost for both community and hospital onset. - Effective clinical management: Quality & Strategy Team at the HTC developed a transitions of care program for patients and is beginning to address transition of care for care givers. Their processes are now being used in HTCs throughout Region VIII of the federal HTC network. - Successful Foundation for the Accreditation of Cellular Therapy (FACT) re-accreditation. FACT accreditation is a threshold for excellence in cellular therapy within the bone marrow or cord blood transplant (BMT) patient population. - Reorganizing the program to a "Door to Door model" providing patients and families a single point of contact to facilitate providing high quality patient care. - Evaluating and changing the Bone Marrow Harvest process to reduce the positive sterility rate of products collected by CHCO providers. |
| FORM 990, PART VI, LINE 1A | CHILDREN'S HOSPITAL COLORADO'S EXECUTIVE COMMITTEE CONSISTS OF THE BOARD CHAIR, CHAIR ELECT, CHIEF EXECUTIVE OFFICER, SECRETARY, BOARD TREASURER, CORPORATE TREASURER, IMMEDIATE PAST CHAIR, THE CHAIR OF THE CHILDREN'S HOSPITAL COLORADO FOUNDATION, THE CHANCELLOR (OR DESIGNEE) AND UP TO TWO (2) ADDITIONAL SEATS TO BE FILLED BY THE BOARD CHAIR. THE EXECUTIVE COMMITTEE HAS ALL THE POWERS OF THE BOARD OF DIRECTORS, EXCEPT AS LIMITED BY LAW, DURING THE PERIOD BETWEEN THE MEETINGS OF THE BOARD OF DIRECTORS, SUBJECT TO ANY PRIOR LIMITATION IMPOSED BY THE BOARD. |
| FORM 990, PART VI, LINE 6 | CHILDREN'S HOSPITAL COLORADO HEALTH SYSTEM IS THE SOLE MEMBER OF CHILDREN'S HOSPITAL COLORADO. |
| FORM 990, PART VI, LINE 7A | THE WRITTEN CONSENT OF CHILDREN'S HOSPITAL COLORADO HEALTH SYSTEM IS REQUIRED TO APPROVE THE BOARD OF DIRECTORS OF CHILDREN'S HOSPITAL COLORADO. |
| FORM 990, PART VI, LINE 7B | CHILDREN'S HOSPITAL COLORADO HEALTH SYSTEM AS THE SOLE MEMBER HAS CERTAIN APPROVAL POWERS AS DESCRIBED IN THE AMENDED AND RESTATED BYLAWS DATED SEPTEMBER 22, 2011 AND AMENDED MOST RECENTLY IN FEBRUARY 2017. |
| FORM 990, PART VI, Line 11B | CHILDREN'S HOSPITAL COLORADO'S FINANCE DEPARTMENT WORKS CLOSELY WITH HUMAN RESOURCES, CORPORATE COMPLIANCE, LEGAL AND PUBLIC RELATIONS TO GATHER ALL THE DATA REQUIRED TO COMPLETE THE FORM 990. THE VP OF FINANCE AND THE DIRECTOR OF ACCTG. & REPORTING CONDUCT A REVIEW WITH THE CFO PRIOR TO THE DRAFT BEING DISTRIBUTED TO THE BOARD OF DIRECTORS. ANY NECESSARY CHANGES ARE MADE, THE FORM IS SIGNED BY THE CFO, REVIEWED BY THE AUDIT COMMITTEE, AND A FINAL COPY IS PROVIDED TO THE BOARD OF DIRECTORS PRIOR TO SUBMISSION TO THE IRS VIA A SECURED WEBSITE. |
| FORM 990, PART VI, LINE 12C | BOARD MEMBERS ARE REQUIRED TO DISCLOSE, ON AN ANNUAL BASIS, POTENTIAL CONFLICTS OF INTEREST PURSUANT TO THE WRITTEN POLICIES OF CHILDREN'S HOSPITAL COLORADO (CHCO) AND CHILDREN'S HOSPITAL COLORADO FOUNDATION (CHCF). ALL EMPLOYEES AND BOARD MEMBERS MUST PROMPTLY PROVIDE A WRITTEN DESCRIPTION OF MATERIAL FACTS OF AN ACTUAL, APPARENT OR POTENTIAL CONFLICT OF INTEREST TO CORPORATE COMPLIANCE AND/OR GENERAL COUNSEL ON THE APPROPRIATE DISCLOSURE FORM. SUCH DISCLOSURE WILL BE MADE PROMPTLY ANY TIME AN ACTUAL, APPARENT OR POTENTIAL CONFLICT OF INTEREST ARISES AND BEFORE THE CONSUMMATION OF THE CONTRACT, TRANSACTION OR ARRANGEMENT THAT IS THE SUBJECT OF THE POTENTIAL CONFLICT OF INTEREST. POLICIES AND PROCEDURES FOR DISCLOSING CONFLICTS OF INTEREST ARE TO BE FOLLOWED ACCORDING TO THE INDIVIDUAL'S FUNCTION, IN COMPLIANCE WITH STATE AND FEDERAL REGULATIONS. COMPLETED DISCLOSURE FORMS ARE SUBJECT TO AUDIT REVIEW BY LEGAL, THE CORPORATE COMPLIANCE PROGRAM, AND THE COMPLIANCE AND BUSINESS ETHICS COMMITTEE OF THE BOARD OF DIRECTORS. FAILURE TO COMPLY WITH CONFLICT OF INTEREST POLICIES MAY LEAD TO DISCIPLINARY ACTION UP TO AND INCLUDING TERMINATION OF EMPLOYMENT OR WORKING RELATIONSHIP WITH THE CHILDREN'S HOSPITAL COLORADO. ONCE THE COMPLIANCE AND BUSINESS ETHICS (CABE) COMMITTEE HAS DETERMINED THAT AN ACTUAL CONFLICT OF INTEREST EXISTS WITH RESPECT TO AN AGREEMENT/CONTRACT THEN: 1. THE (CABE) COMMITTEE WILL EXERCISE DUE DILIGENCE TO DETERMINE WHETHER CHILDREN'S HOSPITAL COULD OBTAIN A MORE ADVANTAGEOUS AGREEMENT/CONTRACT WITH REASONABLE EFFORTS UNDER THE CIRCUMSTANCES AND, IF APPROPRIATE, WILL APPOINT A DISINTERESTED PERSON OR COMMITTEE TO INVESTIGATE ALTERNATIVES TO THE PROPOSED CONTRACT, TRANSACTION OR ARRANGEMENT. 2. IN CONSIDERING WHETHER TO ENTER THE PROPOSED AGREEMENT/CONTRACT, THE CABE COMMITTEE MAY APPROVE SUCH CONTRACT, TRANSACTION OR ARRANGEMENT ONLY IF THE DISINTERESTED PERSON OR COMMITTEE DETERMINE BY A MAJORITY VOTE THAT: - THE PROPOSED CONTRACT, TRANSACTION OR ARRANGEMENT IS IN CHILDREN'S COLORADOS BEST INTERESTS AND FOR COLORADO CHILDREN'S OWN BENEFIT; AND - THE PROPOSED TRANSACTION IS FAIR AND REASONABLE TO CHILDREN'S HOSPITAL COLORADO (CHCO), CONSIDERING, AMONG OTHER RELEVANT FACTORS, WHETHER CHCO COULD OBTAIN A MORE ADVANTAGEOUS CONTRACT, TRANSACTION OR ARRANGEMENT WITH REASONABLE EFFORTS UNDER THE CIRCUMSTANCES. |
| FORM 990, PART VI, LINES 15A AND 15B | CHILDREN'S HOSPITAL COLORADO HAS AN EXECUTIVE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS THAT REVIEWS AND APPROVES ANY PROPOSED INCREASES RELATED TO ANY OFFICERS AND KEY EMPLOYEES OF THE COMPANY. THE CEO'S COMPENSATION IS REVIEWED AND APPROVED BY THE EXECUTIVE COMPENSATION COMMITTEE ALONG WITH THE EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS EACH YEAR. ONCE A CHANGE IN COMPENSATION IS APPROVED, FORMAL DOCUMENTS ARE COMPLETED AND MINUTES OF THE MEETING ARE PREPARED, REVIEWED AND APPROVED. REVIEW PROCESS INCLUDES: - REVIEW MARKET RATIO - SHOULD FALL BETWEEN 80% TO 120% OF MARKET - REVIEW 25TH, 50TH, AND 75TH PERCENTILE - BASE SALARY - INDIVIDUAL QUALIFICATIONS AND PERFORMANCE DETERMINES MARKET POSITION. BASE SALARY FOR EACH INDIVIDUAL IS TARGETED AT THE MEDIAN (50TH PERCENTILE) OF THE PEER GROUP. - VARIABLE PAY - LEADERSHIP INCENTIVE IS IN PLACE WHICH REWARDS FOR ORGANIZATIONAL PERFORMANCE WITH A COMPONENT ALSO BASED ON INDIVIDUAL PERFORMANCE. THE INCLUSION OF VARIABLE PAY WILL PLACE TOTAL CASH COMPENSATION (E.G., BASE SALARY AND VARIABLE PAY) BETWEEN THE 50TH AND 75TH PERCENTILE FOR EACH INDIVIDUAL. - AWARDS ARE BASED ON ACHIEVEMENT OF PRE-ESTABLISHED CHILDREN'S COLORADO GOALS WHICH SUPPORT THE STRATEGIC PLAN - BENEFITS - TARGETED AT THE "MIDDLE OF MARKET" DECISION FACTORS IN EXECUTIVE COMPENSATION DECISIONS: - MARKET DATA FROM INDEPENDENT COMPENSATION SURVEYS THAT REFLECT FUNCTIONALLY COMPARABLE POSITIONS IN ORGANIZATIONS OF SIMILAR SIZE AND SCOPE - DIFFICULTIES IN RECRUITING AND RETAINING EXECUTIVES - SKILLS, EXPERIENCE AND PERFORMANCE HISTORY OF INDIVIDUAL EXECUTIVES - CRITICAL BUSINESS OR STRATEGIC ISSUES THAT THE ORGANIZATION MAY FACE - UTILIZED APPROVED PEER GROUP FROM JANUARY 2018 MEETING - ON POSITIONS WITH INSUFFICIENT DATA (LESS THAN 10 MATCHES) - USED EXPANDED PEER GROUP OF ALL ACUTE CARE ORGANIZATIONS - BENCHMARKED BASE PAY, TOTAL CASH COMPENSATION, AND BENEFITS 2018 CUSTOM PEER GROUP - ATLANTA - BOSTON - CHICAGO - CINCINNATI - COLUMBUS - DALLAS - FORT WORTH - HOUSTON - KANSAS CITY - LOS ANGELES - MILWAUKEE - MINNEAPOLIS - ORANGE - PALO ALTO - PHILADELPHIA - SAN DIEGO - SEATTLE - WASHINGTON, DC THE COMPENSATION REVIEW PROCESS WAS LAST COMPLETED IN 2018. |
| FORM 990, PART VI, LINE 19 | THESE DOCUMENTS ARE MADE AVAILABLE UPON REASONABLE REQUEST. Form 990, Part IX, Line 11g PHYSICIAN SERVICES $ 112,343,732 PURCHASED SERVICES $ 26,647,847 CONSULTING FEES $ 4,920,199 OTHER $ 21,371,387 ------------- TOTAL $ 165,283,165 ============= |
| FORM 990, PART XI, LINE 9 | EQUITY TRANSFER FROM CHCHS $ 6,996,209 EQUITY TRANSFER FROM FOUNDATION $ 29,700,130 CHANGE IN PERPETUAL TRUST ($ 3,524,702) OTHER CHANGES IN NET ASSETS $ 573,476 ------------- TOTAL $ 33,745,113 ============= |
| Software ID: | |
| Software Version: |